Please wait
0000879407424B7EX-FILING FEESCommon stock, par value $0.001 per share 0000879407 2025-03-06 2025-03-06 0000879407 1 2025-03-06 2025-03-06 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
FORM
424(b)(7)
(Form Type)
Arrowhead Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                         
    
Security
Type
  
Security
Class
Title
  
Fee
 Calculation 
or Carry
Forward
Rule
  
Amount
Registered
  
Proposed
Maximum
Offering
Price Per
Unit
  
Maximum
Aggregate
Offering
Price
  
Fee Rate
  
Amount of
Registration
Fee
  
Carry
Forward
Form
Type
  
Carry
Forward
File
Number
  
Carry
Forward 
Initial
effective
date
  
Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         
Fees to
Be
Paid
   Equity  
Common
stock,
par value $0.001
per
share(1)
  
Rule
457(r)
   11,926,301   $17.03   $203,104,906.03(2)   0.0001531   $
31,095.36
          
 
Carry Forward Securities
                         
Carry
Forward
Securities
   N/A   N/A   N/A   N/A     N/A       N/A   N/A   N/A   N/A
                   
   
Total Offering Amounts 
     $203,104,906.03     $31,095.36          
                   
   
Total Fees Previously Paid 
         —           
                   
   
Total Fee Offsets 
         —           
                   
   
Net Fee
Due 
               $31,095.36                
 
(1)
Pursuant to Rule 416 under the Securities Act, this prospectus supplement also covers such an indeterminate amount of
shares
of common stock as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events.
(2)
Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on March 4, 2025 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act). Represents deferred payment of the registration fees in connection with the Registrant’s registration statement on Form
S-3ASR
(Registration
No. 333-268665)
paid with the filing of this prospectus supplement.